跳至主要内容
临床试验/NCT02501304
NCT02501304已完成不适用

Feasibility Study of the ReVENT Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)

Revent Medical International B.V.0 个研究点目标入组 40 人开始时间: 2011年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
主要终点
Apnea-Hypopnea Index (AHI)

研究概览

简要总结

This is a prospective, multi-center, single arm, feasibility study to evaluate the safety and effectiveness of the ReVENT Sleep Apnea System for the treatment of Obstructive Sleep Apnea.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of OSA with AHI 15-40
  • Body Mass Index (BMI) ≤ 32
  • Refused or failed Continuous Positive Airway Pressure (CPAP)
  • Evidence of airway collapse at soft palate and/or base of tongue

排除标准

  • Prior OSA surgery
  • Anatomy unable to accommodate implants
  • Chronic immunosuppressive therapy or known problems with wound healing
  • Type I or II diabetes
  • Active systemic infection
  • Pregnancy
  • Other major medical conditions that could confound outcome measures or interfere with study completion

结局指标

主要结局

Apnea-Hypopnea Index (AHI)

时间窗: 24 months post-procedure

Decrease in polysomnographically measured AHI post-intervention compared to baseline

次要结局

未报告次要终点

研究者

发起方
Revent Medical International B.V.
申办方类型
Industry
责任方
Sponsor

相似试验

Feasibility Study of the ReVENT Sleep Apnea System | 临床试验